RxDoctor Payments DataLook up a doctor →

Ryan Commiskey, NP

Nurse Practitioner · Santa Fe, NMNPI 1922510577

Payments from drug & device makers

$17,611in general payments, 2019–2025

Across 885 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • AstraZeneca$2K
  • Johnson & Johnson$978
  • Exelixis Inc.$826
  • Seagen Inc.$657
  • Bristol Myers Squibb$586
  • plus $10K from 54 others

What the payments were for

  • Food & beverage$15,28587%
  • Education$7484%
  • Other$1,5799%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis91$2,824
AstraZeneca(2 entities)81$1,525
Johnson & Johnson49$978
Exelixis Inc.36$826
Seagen Inc.42$657
Bristol Myers Squibb50$586
Incyte Corporation28$585
Merck30$551
Takeda Pharmaceuticals U.S.A., Inc.17$547
E.r. Squibb & Sons, L.L.C.32$541
Daiichi Sankyo Inc.24$506
Gilead(2 entities)30$489
Sanofi21$454
Genentech USA, Inc.24$424
Eisai Inc.24$424
Pfizer26$385
AbbVie14$337
Bayer20$317
Karyopharm Therapeutics Inc.16$314
Sobi, Inc10$313
Jazz Pharmaceuticals Inc.13$264
Lilly USA, LLC15$242
Regeneron Healthcare Solutions, Inc.10$239
Amgen18$238
Stemline Therapeutics Inc.10$210
Puma Biotechnology, Inc.12$198
Array Biopharma Inc16$197
Beigene USA, Inc.9$175
Blueprint Medicines Corporation7$169
EMD Serono, Inc.6$154
Mirati Therapeutics, Inc.7$150
Genmab U.S., Inc.6$137
Tersera Therapeutics LLC6$133
Boston Scientific5$122
GSK7$111
Kyowa Kirin, Inc.5$98
Taiho Oncology, Inc.7$95
Pharmacyclics LLC, An Abbvie Company4$78
Pharmaessentia USA Corporation4$73
Apellis Pharmaceuticals, Inc.4$64
Ipsen Biopharmaceuticals, Inc3$61
Springworks Therapeutics, Inc.3$54
Beone Medicines USA, Inc.3$53
Servier Pharmaceuticals LLC2$47
Geron Corporation2$45
Deciphera Pharmaceuticals Inc.2$45
EUSA Pharma (US) LLC3$44
AVEO Pharmaceuticals, Inc.2$43
Rigel Pharmaceuticals, Inc.4$42
Boehringer Ingelheim2$36
Astellas Pharma US Inc2$36
Legend Biotech USA Inc.2$33
G1 Therapeutics, Inc.2$32
Dendreon Pharmaceuticals LLC1$30
Pharmacosmos Therapeutics Inc.2$28
Menarini Silicon Biosystems, Inc.1$25
Myovant Sciences Inc.1$24
Acrotech Biopharma Inc.1$23
Heron Therapeutics, Inc.1$21
Nuvation Bio Inc.1$21

How this compares

$17,611 in reported general payments places this provider in the 95th percentile of 624 nurse practitioner providers in New Mexico.

See all nurse practitioner providers in New Mexico →

Medicare billing

Part B allowed, 2024
$93,489
Medicare patients
263
Services billed
1,432

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium38$464
Oxycodone Hcl14$302
Dexamethasone20$286
Ondansetron OdtOndansetron11$183
Acyclovir23$167
Prednisone22$102
Lorazepam16$81

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Santa Fe

See the full list for New Mexico →

Where these figures come from

Is this you, or does something look wrong? →